Northwire Canada EditionThursday, July 23, 2026
Northwire
VZZ 0.180 +2.9% BMR 0.145 +3.6% NVO 0.055 −8.3% PMET 4.47 +2.0% CTG 0.125 +13.6% AVU 0.040 +0.0% SGML 14.32 −3.1% WRLG 0.720 +1.4% CAN 0.065 +8.3% ABRA 15.63 +1.6% LSTR 0.060 +0.0% OLA 13.10 +2.5% EQX 13.15 +2.7% SRA 0.780 +0.0% UTWO 0.390 −13.3% IVN 10.64 −1.2% VZZ 0.180 +2.9% BMR 0.145 +3.6% NVO 0.055 −8.3% PMET 4.47 +2.0% CTG 0.125 +13.6% AVU 0.040 +0.0% SGML 14.32 −3.1% WRLG 0.720 +1.4% CAN 0.065 +8.3% ABRA 15.63 +1.6% LSTR 0.060 +0.0% OLA 13.10 +2.5% EQX 13.15 +2.7% SRA 0.780 +0.0% UTWO 0.390 −13.3% IVN 10.64 −1.2%
M&A / Property

Quipt closes acquisition of 60% of Hart

QIPT · Price

Executive Summary

  • Quipt Home Medical Corp. has closed its previously announced joint venture transaction to acquire a 60% ownership interest in Hart Medical Equipment, financed by senior credit facilities.
  • The acquisition adds approximately $60 million in annual revenue and $7 million in adjusted EBITDA (for the 12 months ended June 2025) to Quipt’s portfolio.
  • Quipt will consolidate Hart’s financial results, bringing its expected annualized run-rate revenue in excess of $300 million and anticipated adjusted EBITDA in excess of $65 million post-integration.

Key Details

  • Transaction Structure: Quipt acquired a 60% controlling interest in Hart Medical Equipment; the remaining 40% is held collectively by Henry Ford Health, McLaren Health Care, Blanchard Valley Health System, Wood County Hospital, and Bellevue Hospital.
  • Consideration: Total consideration of $17.4 million, financed entirely by senior credit facilities.
  • Financial Performance (Hart):
    • Generated approximately $60 million in annual revenue.
    • Generated $7 million in adjusted EBITDA for the 12 months ended June 2025.
    • Expected to generate $10 million+ in annual adjusted EBITDA over the next 6–9 months.
    • Management anticipates Hart’s adjusted EBITDA margins will align with Quipt’s historical corporate averages.
  • Pro Forma Impact:
    • Quipt expects to consolidate Hart’s financial results.
    • Expected annualized run-rate revenue is in excess of $300 million.
    • Upon successful integration (6–9 months), Quipt’s adjusted EBITDA is anticipated to be in excess of $65 million.
    • The 40% non-controlling equity interest will be reported as a separate component on the consolidated statements of financial position.
  • Operational Metrics:
    • Hart serves more than 67,000 patients monthly.
    • Hart is embedded in the hospital discharge processes of more than 19 hospitals and affiliated care facilities across its network.
  • Strategic Rationale: The acquisition provides Quipt with a major entry into Michigan and expanded reach across the Midwest, leveraging Hart’s strong relationships with leading integrated health systems.
  • Advisors: The Braff Group served as exclusive financial adviser for Hart.

Notable Quotes

  • Greg Crawford, CEO and Chairman: "Hart's strong health system relationships and regional market leadership represent a powerful strategic fit. This acquisition demonstrates the scalability of our acquisition platform while providing us with a major entry into Michigan and expanded reach across the Midwest."
  • Hardik Mehta, CFO: "We funded this transaction with our existing credit facility while maintaining a conservative leverage ratio. Importantly, we will look to increase the size of our senior credit facilities, which would provide us with additional flexibility to execute on our robust pipeline..."
  • Allen Hunt, Hart Medical Executive: "In Quipt, we found that partner. Quipt brings more than just scale. Their patient-centred leadership, innovative mindset and cultural alignment with our own make them an ideal match."
Read the original news release →

More from Quipt Home Medical Corp